Equities research analysts at JPMorgan Chase (NYSE: JPM) decreased their price target on shares of Medical Properties Trust (NYSE: MPW) to $10.50 in a research note issued to investors on Tuesday.
The analysts wrote, “After 1Q earnings we are updating our estimates. We are decreasing our 2012 normalized FFO estimate (excluding one-time items) $0.03, to $0.85/share. Our 2012 reported FFO estimate (inclusive of one-time items) is $0.83/share. We are maintaining our 2013 FFO estimate of $1.00/share.”
Separately, analysts at SunTrust (NYSE: STI) initiated coverage on shares of Medical Properties Trust in a research note to investors on Tuesday, May 1st. They set a “buy” rating on the stock.
Shares of Medical Properties Trust opened at 8.94 on Tuesday. Medical Properties Trust has a 52 week low of $8.17 and a 52 week high of $12.65. The company has a market cap of $1.212 billion and a P/E ratio of 40.64.
Medical Properties Trust last announced its earnings results on Thursday, May 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.01. The company’s revenue for the quarter was up 26.5% on a year-over-year basis. On average, analysts predict that Medical Properties Trust will post $0.22 earnings per share next quarter.
Medical Properties Trust, Inc. (Medical Properties Trust) is a self-advised real estate investment trust (REIT) that acquires, develops, leases and makes other investments in healthcare facilities providing healthcare services.
